These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25030844)

  • 1. Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study.
    Kato N; Iwase A; Sugita A; Goto M; Nakahara T; Nakamura T; Kondo M; Osuka S; Mori M; Saito A; Kikkawa F
    Gynecol Endocrinol; 2015 Jan; 31(1):22-5. PubMed ID: 25030844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
    Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
    Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-Müllerian hormone in subfertile women.
    Somigliana E; Lattuada D; Colciaghi B; Filippi F; La Vecchia I; Tirelli A; Baffero GM; Paffoni A; Persico N; Bolis G; Fedele L
    Acta Obstet Gynecol Scand; 2015 Dec; 94(12):1307-12. PubMed ID: 26332870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone as a predictor of reproductive potential.
    Hawkins Bressler L; Steiner A
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):385-390. PubMed ID: 30299431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone levels in salpingectomized compared with nonsalpingectomized women with tubal factor infertility and women with unexplained infertility.
    Grynnerup AG; Lindhard A; Sørensen S
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1297-303. PubMed ID: 24032634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.
    Zarek SM; Mitchell EM; Sjaarda LA; Mumford SL; Silver RM; Stanford JB; Galai N; White MV; Schliep KC; DeCherney AH; Schisterman EF
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4215-21. PubMed ID: 26406293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.
    Fridén B; Sjöblom P; Menezes J
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):411-5. PubMed ID: 21988118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-specific reference values and cut-off points for anti-müllerian hormone in infertile women following a long agonist treatment protocol for IVF.
    Heidar Z; Bakhtiyari M; Foroozanfard F; Mirzamoradi M
    J Endocrinol Invest; 2018 Jul; 41(7):773-780. PubMed ID: 29235049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles.
    Tal R; Seifer DB; Khanimov M; Schwartz E; Grazi RV; Malter HE
    Reprod Biomed Online; 2013 Apr; 26(4):360-7. PubMed ID: 23419793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.
    Dólleman M; Faddy MJ; van Disseldorp J; van der Schouw YT; Messow CM; Leader B; Peeters PH; McConnachie A; Nelson SM; Broekmans FJ
    J Clin Endocrinol Metab; 2013 May; 98(5):1946-53. PubMed ID: 23509105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the utility of anti-Müllerian hormone in female infertility.
    Grynnerup AG; Lindhard A; Sørensen S
    Curr Opin Obstet Gynecol; 2014 Jun; 26(3):162-7. PubMed ID: 24722366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age.
    Wang JG; Douglas NC; Nakhuda GS; Choi JM; Park SJ; Thornton MH; Guarnaccia MM; Sauer MV
    Reprod Biomed Online; 2010 Dec; 21(6):757-61. PubMed ID: 21044868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
    Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of serum anti-Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis.
    Brouwer J; Laven JS; Hazes JM; Schipper I; Dolhain RJ
    Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1534-8. PubMed ID: 23554429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMH concentration is not related to effective time to pregnancy in women who conceive naturally.
    Streuli I; de Mouzon J; Paccolat C; Chapron C; Petignat P; Irion OP; de Ziegler D
    Reprod Biomed Online; 2014 Feb; 28(2):216-24. PubMed ID: 24365018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Müllerian hormone concentration as a biomarker of pregnancy success or failure.
    Szafarowska M; Molinska-Glura M; Jerzak MM
    Neuro Endocrinol Lett; 2014; 35(4):322-6. PubMed ID: 25038595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.